THE ROLE OF LECTIN-TYPE OXIDIZED LDL RECEPTOR 1 (LOX-1) IN PERI-IMPLANTITIS: QUALITATIVE EVIDENCE SYNTHESIS (QES) HIGHLIGHTING THE MECHANISTIC INSIGHTS
Revista Sistemática · 30.07.2026 · 16 (7) · e10749
DOI: 10.56238/rcsv16n7-008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Sistemática, online erschienen am 30.07.2026. Verfasst von Lucas Lopes Pimentel und 2 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To systematically review observational evidence on the role of lectin-type oxidized low-density lipoprotein (LDL) receptor 1 (LOX-1) in the pathogenesis of peri-implantitis. Materials and Methods: An electronic search without restriction on language or publication date was conducted in MEDLINE/PubMed, Cochrane CENTRAL and Embase databases, protocol records and other sources up to April 2023. The clinical question and search strategy were formulated using the PECOD method. Eligibility criteria included observational studies assessing LOX-1’s role in peri-implantitis pathogenesis. The quality of primary studies was assessed using the JBI Critical Appraisal Tools for Analytical Cross-Sectional Studies. Qualitative synthesis followed the SWiM reporting guideline, and the GRADE framework evaluated evidence quality. This systematic review was structured per the PRISMA 2020 statement and registered on OSF (DOI 10.17605/OSF.IO/PQEZJ).
Results
Six studies reported LOX-1’s role in peri-implantitis, highlighting its importance in regulating and signaling inflammatory cytokines such as interleukin 1 beta (IL-1β). Furthermore, LOX-1–dependent production of matrix metalloproteinases 2 (MMP-2) and 9 (MMP-9) induced by Porphyromonas gingivalis in macrophages was demonstrated.
Conclusions
Despite study limitations, findings suggest that LOX-1 mediates increased expression of IL-1β, MMP-2 and MMP-9, regulates Wnt5a, and mediates RANKL production in Pg-stimulated human macrophages, implicating LOX-1 in peri-implantitis pathogenesis. Clinical Relevance: This review provides preliminary evidence associating LOX-1 with peri-implantitis, identifying LOX-1 as a potential therapeutic target.
Zitieren
APA
Pimentel, L. L., Barbirato, D. D. S., & Barros, M. C. M. D. (2026). THE ROLE OF LECTIN-TYPE OXIDIZED LDL RECEPTOR 1 (LOX-1) IN PERI-IMPLANTITIS: QUALITATIVE EVIDENCE SYNTHESIS (QES) HIGHLIGHTING THE MECHANISTIC INSIGHTS. Revista Sistemática, 16(7), e10749. https://doi.org/10.56238/rcsv16n7-008
Vancouver
Pimentel LL, Barbirato DDS, Barros MCMD. THE ROLE OF LECTIN-TYPE OXIDIZED LDL RECEPTOR 1 (LOX-1) IN PERI-IMPLANTITIS: QUALITATIVE EVIDENCE SYNTHESIS (QES) HIGHLIGHTING THE MECHANISTIC INSIGHTS. Revista Sistemática. 2026;16(7):e10749. doi:10.56238/rcsv16n7-008
BibTeX
@article{Pimentel2026,
author = {Pimentel, Lucas Lopes and Barbirato, Davi da Silva and Barros, Maria Cynésia Medeiros de},
title = {THE ROLE OF LECTIN-TYPE OXIDIZED LDL RECEPTOR 1 (LOX-1) IN PERI-IMPLANTITIS: QUALITATIVE EVIDENCE SYNTHESIS (QES) HIGHLIGHTING THE MECHANISTIC INSIGHTS},
journal = {Revista Sistemática},
year = {2026},
volume = {16},
number = {7},
pages = {e10749},
doi = {10.56238/rcsv16n7-008}
}
EUVIMED